Products Name CJC-1295
Molecular Formula C152H252N44O42
1.Appearance :White powder
2.Identity by MS :3368±2
3.Solubility:Soluble in water or 1% acetic acid at a concentration of ≥1mg/ml to give a clear,colorless solution
4.Peptide Purity (By HPLC) :≥98.0%
5.Related Substance(By HPLC): Total Impurities(%)≤ 2.0%
Largest Single impurity(%)≤ 1.0%
6.Acetate Content(HPLC) :≤ 15.0%
7.Water Content(Karl Fischer) :≤ 6.0%
8.Bacterial Endotoxins : ≤ 5EU/mg
9.Assay(by anhydrous,acetic acid-free) :95.0~105.0%
CJC-1295 is a tetrasubstituted 30-amino acerbic peptide hormone, primarily activity as a advance hormone absolution hormone (GHRH) analog. It was invented by ConjuChem, a Canadian biotechnology company.
One of the advantages of CJC-1295 over acceptable GHRH or rHGH is its adeptness to bioconjugate with serum albumin, appropriately accretion its half-life and ameliorative window. It accomplishes this by application attention groups about the amino acids of GHRH about affected to enzymatic degradation.
ConjuChem accomplished analytic trials for CJC-1295 during the mid-2000s. The cold of the biologic was to amusement belly fat deposits in adipose AIDS patients, as added levels of exogenous HGH are accepted to access lipolysis (fat loss). The balloon was ultimately acknowledged for a lot of analysis subjects, but the drug's business adjourned if three of the trial's patients suffered a myocardial infarction.
More about: CJC-1295 Sales